Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Different treatment strategies for BRCA positive breast cancer

Prof Banu Arun - MD Anderson Center, Houston, USA
Different treatment strategies for BRCA positive breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )
25 Jan 2018

Neoadjuvant and adjuvant therapy in triple negative breast cancer

Prof Banu Arun - MD Anderson Center, Houston, USA
Neoadjuvant and adjuvant therapy in triple negative breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )
25 Jan 2018

The DESKTOPIII trial in platinum-sensitive ovarian cancer

Prof Sean Kehoe - University of Birmingham, Birmingham, UK
The DESKTOPIII trial in platinum-sensitive ovarian cancer ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )
24 Jan 2018

Expert insight: Managing neutropenia in breast cancer patients

Dr Matti Aapro and Prof Hope Rugo
Expert insight: Managing neutropenia in breast cancer patients ( Dr Matti Aapro and Prof Hope Rugo )
23 Jan 2018

Focus on screening, not biomarkers

Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands
Focus on screening, not biomarkers ( Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands )
14 Dec 2017

Venetoclax plus rituximab for patients with relapsed / refractory CLL

Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Venetoclax plus rituximab for patients with relapsed / refractory CLL ( Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2017

Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma

Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Dec 2017

Multiple myeloma analysis from ASH 2017

Dr Maxim Solovev and Dr Sung-Soo Yoon
Multiple myeloma analysis from ASH 2017 ( Dr Maxim Solovev and Dr Sung-Soo Yoon )
12 Dec 2017

Multiple myeloma highlights from ASH 2017

Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey
Multiple myeloma highlights from ASH 2017 ( Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey )
12 Dec 2017

ASH 2017: Immunotherapy for multiple myeloma

Prof Paul Richardson & Dr Wenming Chen
ASH 2017: Immunotherapy for multiple myeloma ( Prof Paul Richardson &  Dr Wenming Chen )
12 Dec 2017

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma

Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
11 Dec 2017

REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies

Dr Max Topp - University of Wurzburg, Wurzburg, Germany
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies ( Dr Max Topp - University of Wurzburg, Wurzburg, Germany )
11 Dec 2017